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Ten years ago, European officials, experts and other stakeholders 
met in Copenhagen, Denmark, at the invitation of the Danish 
Ministry of Health and the Danish Ministry of Food, Agriculture 
and Fisheries. This European conference on “The Microbial Threat” 
due to antimicrobial resistance resulted in the publication of 
“Copenhagen Recommendations” calling for action to limit the 
emerging problem of antimicrobial-resistant microorganisms [1]. 
Following the conference, the European Commission prepared 
a comprehensive Community strategy against antimicrobial 
resistance, which was published in 2001 [2] and presented in 
Eurosurveillance [3]. Later the same year, European Union (EU) 
Health Ministers adopted a Council Recommendation on the prudent 
use of antimicrobial agents in human medicine with a series of 
specific measures aimed at containing the spread of antimicrobial 
resistance by prudent use of antimicrobial agents [4].
A review article published in this journal in 2001 showed that 
only six European countries had a national action plan to contain 
antimicrobial resistance [5]. An evaluation of implementation of the 
Council Recommendation performed by the European Commission 
showed that, by 2003, 16 countries had developed a national 
strategy to contain antimicrobial resistance and nine countries 
had an action plan [6,7]. The European Commission is currently 
performing another evaluation of the implementation of the Council 
Recommendation and its results will be available in 2009.
Historically, Denmark was the first European country to report on 
the control of methicillin-resistant Staphylococcus aureus (MRSA), 
which took place at the end of the 1960s and in the 1970s. 
Although the interventions were never fully documented, this 
decrease in the percentage of MRSA in S. aureus blood isolates from 
more than 30% to less than 1% - a figure that still holds today - has 
been attributed to a more prudent use of antbiotics combined with 
increased awareness of hospital hygiene [8]. In Iceland, a public 
media campaign on the prudent use of antibiotics in children in the 
mid-1990s led to a change in parents’ attitudes, to a reduction in 
antimicrobial use and, subsequently, to a decrease in the incidence 
of penicillin-non-susceptible Streptococcus pneumoniae which had 
increased rapidly at the beginning of the decade [9]. This issue of 
Eurosurveillance is the first of two special issues on antimicrobial 
resistance and focuses on the recent successes of several EU 
Member States in reverting trends in antimicrobial resistance 
or, for the Netherlands, in maintaining already low antimicrobial 
resistance rates.
Among the six countries reporting in this issue of Eurosurveillance, 
the French success is remarkable because this country, which had 
the highest outpatient antibiotic consumption per capita in the EU, 
has been able to reduce this consumption by 16% between 2000 
and 2006 following repeated annual public awareness campaigns 
on the prudent use of antibiotics combined with interventions 
targeted at general practitioners, including academic detailing and 
promotion of rapid testing for Streptococcus pyogenes tonsillitis 
[10]. This decrease in antibiotic use combined with the introduction 
of the 7-valent protein conjugated pneumococcal vaccine for 
young children in 2002 resulted in reverting trends in penicillin 
resistance in S. pneumoniae [10]. Additionally, several data 
sources confirm a decrease in the incidence and the prevalence 
of MRSA. For example, data from the European Antimicrobial 
Resistance Surveillance System (EARSS) show a decrease in 
the proportion of MRSA in S. aureus from blood cultures from 
France, from 33% in 2001 to 26% in 2007 [11]. This decrease 
has been attributed to the gradual expansion of infection control 
structures as well as implementation of specific MRSA control 
measures in French hospitals [10]. In Belgium, national activities 
to contain antimicrobial resistance have been coordinated by the 
Belgian Antibiotic Policy Coordination Committee (BAPCOC) since 
1999. Yearly public awareness campaigns on antibiotics since 
2000 have resulted in a 32% decrease in antibiotic consumption 
when expressed in packages and a concomitant decrease in, e.g. 
macrolide resistance in S. pneumoniae and S. pyogenes [12]. 
However, France and Belgium remain among the European countries 
with the highest consumption of antibiotics per capita and have 
therefore decided to continue organising national public awareness 
campaigns each year to consolidate their progress towards prudent 
use of antibiotics.
Other European countries with much lower levels of antimicrobial 
consumption and resistance have shown success with their national 
actions on prudent use of antibiotics and infection control. Through 
repeated reports in the media and the introduction of rapid diagnostic 
tests, Slovenia was able to show a 20% decrease in antibiotic 
consumption in outpatients, although this decrease has so far not 
been followed by a concomitant decrease in resistance. In Slovenian 
healthcare facilities, the introduction of a comprehensive national 
strategy for MRSA control resulted in a decrease in the proportion 
of MRSA in S. aureus from blood cultures from 21% in 2000 to 
8% in 2007 [13]. In the Czech Republic, an education programme 
targeted at primary care paediatricians, including repeated audits of 
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prescribing practices and feedback, was implemented in 2001 as 
a control measure following increasing antibiotic consumption and 
resistance in the community in the 1990s [14]. In Sweden, national 
activities are coordinated by the Swedish Strategic Programme 
Against Antibiotic Resistance (STRAMA) and relayed at county level 
by a network of local STRAMA groups. Regular collaboration with 
national and regional media combined with local activities resulted 
in a 22% decrease in outpatient antibiotic consumption between 
1994 and 2004 [15]. Finally, the Netherlands still have the lowest 
outpatient antibiotic consumption per capita in the EU as reported 
by European Surveillance of Antimicrobial Consumption (ESAC) 
[16], with antimicrobial resistance proportions that are among the 
lowest registered by the EARSS [11]. A Dutch Working Party on 
Antibiotic Policy (SWAB) was created in 1996 to ensure that the 
low level of antimicrobial resistance is preserved while improving 
the quality of antimicrobial prescriptions through the development 
of guidelines education and surveillance [17]. 
These experiences from European countries are encouraging. They 
show that it is possible to turn the tide of antimicrobial resistance 
through prudent use of antibiotics, better infection control practices 
and use of vaccines. The challenge is now to get all European 
countries take similar action. On 10 June 2008, EU Health Ministers 
adopted the Council Conclusions on antimicrobial resistance that 
reiterated their call for action to contain antimicrobial resistance 
and called upon Member States “to ensure that structures and 
resources for the  implementation of the Council recommendation 
on the prudent use of antimicrobial agents in human medicine 
are in place and to continue with the implementation of specific 
strategies targeted towards the containment of the antimicrobial 
resistance” [18]. The Council also called upon the Commission 
and Member States “to coordinate an annual European initiative 
to increase awareness of the general public and veterinary and 
healthcare professionals about antimicrobial resistance, the prudent 
use of antibiotics in humans and animals and infection control 
practices”. On 18 November 2008, the first European Antibiotic 
Awareness Day will be launched at the European Parliament in 
Strasbourg and marked in 29 European countries. This European 
health initiative coordinated by the European Centre for Disease 
Prevention and Control will in 2008 focus on increasing awareness 
of the general public about prudent use of antibiotics, based on 
the experience of a number of pioneer Member States reporting in 
this issue of Eurosurveillance. More information about European 
Antibiotic Awareness Day can be found at: http://antibiotic.ecdc.
europa.eu.
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